Plunkett Research Online: Kaleido Biosciences Inc

KALEIDO BIOSCIENCES INC (KLDO:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Kaleido Biosciences, Inc. is a clinical-stage healthcare company with a chemistry-driven approach to leveraging the microbiome organ to treat disease and improve human health. This approach focuses on developing novel microbiome metabolic therapies (MMTs) to drive functional outputs of the microbio.....



Kaleido Biosciences Inc
Ticker: KLDO
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 617-674-9000
Fax:
Address: 65 Hayden Avenue
Lexington, MA 02421 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Biological Product (except Diagnostic) Manufacturing
Contacts Description

Alison Lawton CEO/Pres.
Stephen Sofen Sr. VP-IT
See More
Kaleido Biosciences, Inc. is a clinical-stage healthcare company with a chemistry-driven approach to leveraging the microbiome organ to treat disease and improve human health. This approach focuses on developing novel microbiome metabolic therapies (MMTs) to drive functional outputs of the microbio.....See More See More

Auditor: Deloitte & Touche LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017 2016
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Cadena Bio Inc
Kaleido Biosciences Securities Corporation
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: